Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery

被引:1
作者
Du, Zhongze [1 ]
Sun, Hao [1 ]
Zhao, Ruihu [1 ]
Deng, Guiming [1 ]
Pan, Hongming [1 ]
Zuo, Yanjiao [1 ]
Huang, Rong [1 ]
Xue, Yingwei [1 ]
Song, Hongjiang [1 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Gastrointestinal Surg, Harbin, Heilongjiang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
prognostic nutritional index; IgM; gastric cancer; surgery; prognosis; NEOADJUVANT CHEMOTHERAPY; PLUS CISPLATIN; D2; GASTRECTOMY; CAPECITABINE; CACHEXIA; SURVIVAL; THERAPY; TRIAL; SCORE; PNI;
D O I
10.3389/fonc.2023.1113428
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveAlthough the survival rate of patients who undergo surgery for gastric cancer has greatly improved, still many patients have a poor prognosis. This retrospective study aimed to investigate the predictive ability of the PNI-IgM score, a combined prognostic nutritional index (PNI), and immunoglobulin M (IgM), on the prognosis of patients undergoing surgery for gastric cancer. Methods340 patients with gastric cancer who underwent surgery from January 2016 to December 2017 were selected. The PNI-IgM score ranged from 1 to 3: score of 1, low PNI (< 48.45) and low IgM (< 0.87); score of 2, low PNI and high IgM, or high PNI and low IgM; score of 3, high PNI and high IgM. We compared the differences in disease-free survival (DFS) and overall survival (OS) among the three groups, while univariate and multivariate analyses calculated prognostic factors for DFS and OS. In addition, the nomograms were constructed based on the results of multivariate analysis to estimate the 1-, 3- and 5-year survival probability. ResultsThere were 67 cases in the PNI-IgM score 1 group, 160 cases in the PNI-IgM score 2 group, and 113 cases in the PNI-IgM score 3 group. The median survival times of DFS in the PNI-IgM score group 1, the PNI-IgM score group 2, and the PNI-IgM score group 3 were 62.20 months, not reached, and not reached, and 67.57 months vs. not reached vs. not reached in three groups for OS. Patients in the PNI-IgM score group 1 had a lower DFS than the PNI-IgM score group 2 (HR = 0.648, 95% CI: 0.418-1.006, P = 0.053) and the PNI-IgM score group 3 (HR = 0.337, 95% CI: 0.194-0.585, P < 0.001). In stratified analysis, PNI-IgM score 1 had a worse prognosis in the age < 60 years group and CA724 < 2.11 U/m group. ConclusionPNI-IgM score is a novel combination of nutritional and immunological markers that can be used as a sensitive biological marker for patients with gastric cancer who undergo surgery. The lower the PNI-IgM score, the worse the prognosis.
引用
收藏
页数:14
相关论文
共 49 条
  • [11] Measurement of the IgM and IgG Autoantibody Immune Responses in Human Serum has High Predictive Value for the Presence of Colorectal Cancer
    Fitzerald, Sean
    O'Reilly, Julie-Ann
    Wilson, Erin
    Joyce, Ann
    Farrell, Richard
    Kenny, Dermot
    Kay, Elaine Williamson
    Fitzgerald, Jenny
    Byrne, Barry
    Kijanka, Gregor Stefan
    O'Kennedy, Richard
    [J]. CLINICAL COLORECTAL CANCER, 2019, 18 (01) : E53 - E60
  • [12] Nutritional Therapy in Gastrointestinal Cancers
    Garla, Priscila
    Waitzberg, Dan Linetzky
    Tesser, Alweyd
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2018, 47 (01) : 231 - +
  • [13] Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
    Guo, Yizhen
    Wei, Lai
    Patel, Sandip H.
    Lopez, Gabrielle
    Grogan, Madison
    Li, Mingjia
    Haddad, Tyler
    Johns, Andrew
    Ganesan, Latha P.
    Yang, Yiping
    Spakowicz, Daniel J.
    Shields, Peter G.
    He, Kai
    Bertino, Erin M.
    Otterson, Gregory A.
    Carbone, David P.
    Presley, Carolyn
    Kulp, Samuel K.
    Mace, Thomas A.
    Coss, Christopher C.
    Phelps, Mitch A.
    Owen, Dwight H.
    [J]. CLINICAL LUNG CANCER, 2022, 23 (04) : 345 - 355
  • [14] Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review
    Hauser, Catherine A.
    Stockler, Martin R.
    Tattersall, Martin H. N.
    [J]. SUPPORTIVE CARE IN CANCER, 2006, 14 (10) : 999 - 1011
  • [15] Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer
    Hirahara, Tetsushi
    Arigami, Takaaki
    Yanagita, Shigehiro
    Matsushita, Daisuke
    Uchikado, Yasuto
    Kita, Yoshiaki
    Mori, Shinichiro
    Sasaki, Ken
    Omoto, Itaru
    Kurahara, Hiroshi
    Maemura, Kosei
    Okubo, Keishi
    Uenosono, Yoshikazu
    Ishigami, Sumiya
    Natsugoe, Shoji
    [J]. BMC CANCER, 2019, 19 (1)
  • [16] Prognostic Significance of PNI in Patients With Pancreatic Head Cancer Undergoing Laparoscopic Pancreaticoduodenectomy
    Jiang, Peng
    Li, Xiaocheng
    Wang, Shupeng
    Liu, Yahui
    [J]. FRONTIERS IN SURGERY, 2022, 9
  • [17] Challenges in the treatment of gastric cancer in the older patient
    Joharatnam-Hogan, Nalinie
    Shiu, Kai Keen
    Khan, Khurum
    [J]. CANCER TREATMENT REVIEWS, 2020, 85
  • [18] Natural IgM in Immune Equilibrium and Harnessing Their Therapeutic Potential
    Kaveri, Srini V.
    Silverman, Gregg J.
    Bayry, Jagadeesh
    [J]. JOURNAL OF IMMUNOLOGY, 2012, 188 (03) : 939 - 945
  • [19] Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review
    Langius, Jacqueline A. E.
    Zandbergen, Myrna C.
    Eerenstein, Simone E. J.
    van Tulder, Maurits W.
    Leemans, C. Rene
    Kramer, Mark H. H.
    Weijs, Peter J. M.
    [J]. CLINICAL NUTRITION, 2013, 32 (05) : 671 - 678
  • [20] Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
    Lee, Jeeyun
    Lim, Do Hoon
    Kim, Sung
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Choi, Min Gew
    Sohn, Tae Sung
    Noh, Jae Hyung
    Bae, Jae Moon
    Ahn, Yong Chan
    Sohn, Insuk
    Jung, Sin Ho
    Park, Cheol Keun
    Kim, Kyoung-Mee
    Kang, Won Ki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 268 - 273